China TCM Makers In $431 Million Buyout Of Tongjitang
This article was originally published in PharmAsia News
Executive Summary
A Shanghai Fosun Pharmaceutical Group unit and Hanmax have sold their entire stakes in Tongjitang Chinese Medicines to Winteam Pharmaceutical Group for $431 million, the Hong Kong-based buyer said.